We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma (MIITOP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00960739
Recruitment Status : Completed
First Posted : August 18, 2009
Last Update Posted : August 8, 2016
National Cancer Institute, France
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Centre Oscar Lambret

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2016
  Study Completion Date : July 2016